Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System)

Circulation. 2018 Feb 6;137(6):633-635. doi: 10.1161/CIRCULATIONAHA.117.030106.
No abstract available

Keywords: arrhythmias, cardiac; cardiac pacing, artificial; long term adverse effects; pacemaker, artificial.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / therapy*
  • Cardiac Pacing, Artificial / adverse effects*
  • Cardiac Pacing, Artificial / mortality
  • Clinical Trials as Topic
  • Equipment Design
  • Female
  • Humans
  • Male
  • Pacemaker, Artificial* / adverse effects
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome